H-CYTE, Inc. (HCYT) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Tampa, FL, United States. El CEO actual es Michael W. Yurkowsky.
HCYT tiene fecha de IPO 2014-12-19, 2 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $624.98K.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
